Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Advances in the Understanding of Etiology (I)
-
1. Infection and autoimmunity: a two-way relationship
- Dr. Ricard Cervera
-
2. Autoimmunity and atherosclerosis
- Prof. Johan Frostegard
-
3. Endothelium and autoimmunity
- Prof. Pier Luigi Meroni
- Advances in the Understanding of Etiology (II)
-
4. Prolactin has a pathogenic role in systemic lupus erythematosus
- Prof. Luis Jara-Quezada
-
5. Sjögren's syndrome: current knowledge and future prospects
- Prof. Athanasios G. Tzioufas
-
6. Genetic and environmental triggers of autoimmune thyroid diseases
- Prof. Yaron Tomer
- Advances in Pathogenesis and Clinical Manifestation
-
8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes
- Dr. Luís Eduardo Coelho Andrade
-
9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens
- Dr. Luís Eduardo Coelho Andrade
-
10. What causes primary biliary cholangitis?
- Dr. M. Eric Gershwin
-
11. Capillaroscopy in autoimmune rheumatic diseases
- Prof. Maurizio Cutolo
- Advances in Diagnostic Methodologies (I)
-
12. The past, present & future of ANA testing: history and challenges of ANA
- Prof. Marvin J. Fritzler
-
13. The past, present & future of ANA testing: changing bandwidth and future of ANA
- Prof. Marvin J. Fritzler
-
14. Diagnostic methods in autoimmunity
- Mr. Steven Binder
-
15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
17. Novel aspects of systemic sclerosis
- Prof. Gabriele Valentini
- Advances in Diagnostic Methodologies (II)
-
18. An update on the multiple faces of celiac disease
- Prof. Aaron Lerner
-
19. Protective autoantibodies
- Prof. Elias Toubi
-
21. Rheumatic fever: a model of a post-infectious autoimmune disease
- Prof. Jorge Kalil
- Treatments of autoimmune diseases
-
22. Intravenous immunoglobulins: clinical evidence
- Prof. Shaye Kivity
- Latest Developments in the Field
-
23. Adjuvants and autoimmunity
- Dr. Eitan Israeli
-
24. Antiphospholipid syndrome (APS): from pathogenesis to treatment
- Prof. Roger Levy
-
25. Vitamin D and autoimmunity
- Dr. Shir Azrielant
-
26. Pregnancy in rheumatic diseases
- Prof. Pier Luigi Meroni
- Archived Lectures *These may not cover the latest advances in the field
-
27. Pathogenic mechanisms of autoantibodies
- Prof. Cees Kallenberg
-
28. B lymphocytes on the frontline of autoimmunity
- Prof. Pierre Youinou
-
29. Apoptotic cell clearance deficiency
- Prof. Martin Herrmann
-
30. Auto-antibodies as predictors of autoimmune disease
- Dr. Nicola Bizzaro
-
31. Innate immunity and natural autoantibodies
- Prof. Luc Mouthon
-
32. Accelerated atherosclerosis in autoimmune rheumatic disease
- Dr. Andrea Doria
-
33. Pregnancy in autoimmune rheumatic diseases
- Prof. Angela Tincani
-
36. Immunologic mechanisms in systemic lupus erythematosus
- Prof. Kok-Yong Fong
-
37. Osteoimmunology
- Prof. João Eurico Fonseca
- Ms. Joana Caetano-Lopes
-
38. ANCA-associated systemic vasculitides
- Prof. Loic Guillevin
-
39. The common origin for diverse autoimmune diseases
- Prof. Juan-Manuel Anaya
-
40. Anti-cytokine therapy in rheumatoid arthritis
- Prof. Piercarlo Sarzi-Puttini
-
41. Sjogren's syndrome: autoimmune epithelitis
- Prof. Haralampos Moutsopoulos
-
42. Vitamin D and autoimmunity
- Dr. Howard Amital
-
43. Intravenous immunoglobulins: myth and reality
- Prof. Zera Tellier
Printable Handouts
Navigable Slide Index
- Introduction
- AITD
- Etiology of AITD - infection
- Epidemiological evidence
- Infection and AITD
- Molecular mimicry
- Bystander activation
- Etiology of AITD - iodine
- Iodine and AITD
- Iodine and AITD - mechanisms
- Etiology of AITD - stress
- Stress and Graves’ disease (GD)
- Etiology of AITD - smoking
- Smoking and AITD
- Smoking and AITD - summary
- Environmental risk factors for AITD
- Evidence for genetic susceptibility
- AITD cluster in families - Amsterdam cohort
- AITD cluster in families
- Genetic susceptibility to AITD
- Twin studies in AITD
- Methods for identifying complex disease genes
- Identifying susceptibility genes for diseases
- Gene susceptibility identification model
- Susceptibility genes identified in AITD
- Putative AITD susceptibility genes in Caucasians
- The immunological synapse
- HLA-DR in GD
- HLA associations in GD (caucasians)
- HLA-DR sequence variants association with GD
- Amino acid sequences of HLA-DR3 subtypes
- HLA-DR peptide binding groove
- Structure of the peptide binding groove
- Suggested mechanism
- HLA-DR summary
- The CTLA-4 gene in AITD (2q)
- Function of CTLA-5
- CTLA-4 studies in AITD (Caucasians)
- Which variant causes autoimmunity?
- These polymorphisms are in LD
- Functional studies
- Blocking CTLA-4 augments T-cell proliferation
- Genotype association with reduced CTLA-4
- Direct functional studies
- Causative polymorphism mapping
- CTLA-4 summary
- The CD40 gene in GD
- Function of CD40
- A new SNP in the Kozak sequence of CD40
- The CD40 Kozak SNP in GD
- Kozak sequences and translation
- Kozak SNP and CD40 translation
- In vitro transcription/translation assay for CD40
- CD40 surface expression on Rat2 cells
- CD40 expression on B cells
- FACS analysis of CD19+CD40+ purified B cells
- Higher cell surface expression of CD40
- Increased CD40 expression – where?
- Transgenic mice over-expressing CD40 on TFC
- Experimental autoimmune GD (EAGD)
- TRAb levels in EAGD mice
- Increase in T4 levels in EAGD mice
- CD40 expression induce or accelerate GD
- CD40 signaling pathways
- Canonical pathway activation
- Non-canonical pathway activation
- CD40 summary
- Development of AITD
Topics Covered
- Autoimmune thyroid diseases (AITD)
- Identification of AITD susceptibility genes
- Iodine and AITD
- MHC class II genes, CTLA-4, and CD40
- Sequencing efforts
- Environmental and genetic triggering factors of AITD
- Genetic studies and etiology of AITD
- Development of AITD
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Tomer, Y. (2018, October 31). Genetic and environmental triggers of autoimmune thyroid diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/OFGO5628.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Yaron Tomer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
The topic of my talk is
"Genetic and Environmental Triggers of Autoimmune Thyroid Diseases".
0:08
Autoimmune thyroid diseases are believed to develop as a result of
an interaction between genetic factors and environmental triggers.
This interaction leads to
the final disease phenotype which could be Graves' disease which manifests
clinically by hyperthyroidism or
Hashimoto's thyroiditis which manifests clinically by hypothyroidism.
0:34
I will first discuss the environmental triggers of autoimmune thyroid diseases.
I will discuss infection, iodine exposure, stress,
and smoking as triggers of autoimmune thyroid diseases.
I will start by discussing infection.
0:54
There is abundant epidemiological evidence for
an infectious trigger of autoimmune thyroid diseases.
For example, in one study from the United Kingdom,
there was seasonality in the presentation of Graves' disease with
more cases appearing in the summer than in other seasons.
In another study, there was evidence for
recent bacterial or viral infection in 36 percent of newly diagnosed Graves' patients.
And in a mouse model of Graves' disease,
it was found that mice bread in
a conventional facility where they are exposed to many infectious agents they developed
higher and more persistent levels of
TSH receptor antibodies compared to mice bread in a pathogen-free facility.